Psychiatry and Behavioral Sciences
Psychiatry Grand Rounds Speaker
F. Joseph McClernon , Ph.D.
Joseph (Joe) McClernon, Ph.D. is Associate Professor of Psychiatry and Behavioral Sciences and Director of the Tobacco Research Laboratory at Duke University Medical Center. He earned a Ph.D. in clinical psychology in 2001 from Southern Illinois University-Carbondale after completing clinical internship at the Medical University of South Carolina. Dr. McClernon finished postdoctoral training in behavioral pharmacology under Dr. Jed Rose at the Duke Center for Nicotine and Smoking Cessation Research in 2002.
Dr. McClernon’s research is broadly focused on elucidating the neurocognitive basis of nicotine dependence, withdrawal and relapse using behavioral pharmacology, neuroimaging and molecular genetic approaches. Related research areas include: psychiatric illness-nicotine dependence comorbidity; the effects of nicotine on affect and cognition; and the development and evaluation of novel smoking cessation treatments. He is currently PI on a NIDA-funded K23 award and on R01s investigating 1) the role of nicotine and non-nicotine components of tobacco smoke on neurocognition and 2) brain function correlates of smoking cessation outcomes. He is also funded by the Robert C. and Veronica Atkins Foundation to investigate the neural basis of food craving.
Dr. McClernon has been the recipient of young investigator travel awards from the American College of Neuropsychopharmacology (2006) and the Society for Research on Nicotine and Tobacco (SRNT, 2005). He has been named the 2009 recipient of the SRNT Jarvik-Russell Young Investigator Award. Dr. McClernon has authored more than 40 peer-reviewed publications and regularly serves on NIH review panels.
|At the completion of this session, the participant should be able to:|
1) Discuss relations between ADHD diagnosis/symptoms and smoking prevalence, onset and relapse.
2) Discuss ADHD/non-ADHD differences in smoking withdrawal and cessation treatment response.
3) Discuss the role of impulsivity in smoking relapse and the effects of smoking abstinence on brain function during inhibitory control.